ACADIA Pharmaceuticals
ACAD
#3635
Rank
ยฃ2.66 B
Marketcap
ยฃ15.65
Share price
-3.35%
Change (1 day)
17.90%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of December 2025 : ยฃ39.35 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is ยฃ39.35 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2025-12-31ยฃ38.75 M-6.47%
2024-12-31ยฃ41.43 M-7.72%
2023-12-31ยฃ44.9 M-12.38%
2022-12-31ยฃ51.24 M7.37%
2021-12-31ยฃ47.73 M31.31%
2020-12-31ยฃ36.34 M386.63%
2019-12-31ยฃ7.46 M
2018-12-31N/A
2011-12-31ยฃ0.02 M-71.11%
2010-12-31ยฃ0.07 M-75.1%
2009-12-31ยฃ0.28 M-65.77%
2008-12-31ยฃ0.83 M-22.19%
2007-12-31ยฃ1.07 M-11.41%
2006-12-31ยฃ1.21 M17.34%
2005-12-31ยฃ1.03 M-21.59%
2004-12-31ยฃ1.31 M-51.56%
2003-12-31ยฃ2.72 M-32.2%
2002-12-31ยฃ4.01 M339.76%
2001-12-31ยฃ0.91 M-76.47%
2000-12-31ยฃ3.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ36.14 B 91,748.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ48.23 B 122,461.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ32.05 B 81,343.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.54 B 90,227.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
ยฃ8.23 M-79.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA